YOKNEAM, Israel, Oct. 1, 2024
/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global
provider of innovative medical technologies today announced the
departure of Shakil Lakhani,
President of North America
effective September 30, 2024. His
departure follows that of Dr. Spero
Theodorou, Chief Medical Officer, and Dan Wilson, VP of Sales USA.
In addition to the departure of the three executives from
InMode's North American operations, over the last few months,
InMode has changed the management teams in three of its
subsidiaries in Europe: InMode UK,
InMode Iberia and InMode France.
These changes come as part of InMode's ongoing effort to
establish an optimal company structure that aligns with its global
expansion and penetration into new business verticals. As the
Company continues to expand into the wellness sector, it has become
clear that a reorganization is necessary to ensure that InMode has
the right structure, and skill sets in place to support future
goals.
InMode has a full pipeline of new platforms, with over a dozen
already in the market and more on the horizon. To manage this
growth effectively, the role of President of North America will be divided into separate
roles, each providing the focus needed for the Company's evolving
business landscape.
Moshe Mizrahy, InMode's CEO,
said, "This new structure is designed to enhance operational
efficiency of our North American operations. This reorganization
marks an important step in InMode's evolution as a global company
and demonstrates our commitment to building a robust infrastructure
for future growth. I will be working closely with the executive
team in North America to guide
this transition.
"We thank Shakil, Dr. Theodorou, and Dan, and wish them the best
of luck in their future endeavors. We look forward to the exciting
opportunities ahead," concluded Moshe
Mizrahy.
About InMode
InMode is a leading global provider of innovative medical
technologies. InMode develops, manufactures, and markets devices
harnessing novel radiofrequency ("RF") technology. InMode strives
to enable new emerging surgical procedures as well as improve
existing treatments. InMode has leveraged its medically accepted
minimally invasive RF technologies to offer a comprehensive line of
products across several categories for plastic surgery, gynecology,
dermatology, otolaryngology, and ophthalmology. For more
information about InMode and its wide array of medical
technologies, visit www.inmodemd.com.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
917-607-8654
Logo:
https://mma.prnewswire.com/media/1064477/4845303/InMode_Logo.jpg
View original content to download
multimedia:https://www.prnewswire.com/news-releases/inmode-announces-departures-of-president-of-north-america-chief-medical-officer-and-vp-of-sales-usa-as-part-of-a-global-reorganization-strategy-302263201.html
SOURCE InMode LTD